Medical Research Council-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2021

  1. Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

    ESMO Open, Vol. 6, Núm. 2

2013

  1. Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: A meta-analysis using individual patient data

    Annals of Oncology, Vol. 24, Núm. 12, pp. 3028-3034

2011

  1. Clinical trials in recurrent ovarian cancer

    International Journal of Gynecological Cancer